Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple Sclerosis”
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00355134. IPD Sharing: Not stated. Countries: 8. Publications: 6.
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
ClinicalTrials.gov study NCT00483652. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01006265. IPD Sharing: Not stated. Countries: 23. Publications: 2.
Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01064401. IPD Sharing: Not stated. Countries: 28. Publications: 7.
Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01051349. IPD Sharing: Not stated. Countries: 8. Publications: 3.
A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
ClinicalTrials.gov study NCT05119569. IPD Sharing: YES. Countries: 6. Publications: 1.
Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients
ClinicalTrials.gov study NCT03183869. IPD Sharing: NO. Countries: 1. Publications: 9.
Investigating the Impact of Sex Hormones in Multiple Sclerosis
ClinicalTrials.gov study NCT07081594. IPD Sharing: YES. Countries: 0. Publications: 4.
Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT01226745. IPD Sharing: Not stated. Countries: 11. Publications: 0.
A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis
ClinicalTrials.gov study NCT00876447. IPD Sharing: Not stated. Countries: 22. Publications: 1.
Vitamin D Supplementation in Multiple Sclerosis
ClinicalTrials.gov study NCT01490502. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT01247324. IPD Sharing: Not stated. Countries: 32. Publications: 16.
Safety and Tolerability of Quetiapine in Multiple Sclerosis
ClinicalTrials.gov study NCT02087631. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT03222973. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
ClinicalTrials.gov study NCT02760056. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
ClinicalTrials.gov study NCT00475865. IPD Sharing: Not stated. Countries: 6. Publications: 1.
An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
ClinicalTrials.gov study NCT01610713. IPD Sharing: Not stated. Countries: 1. Publications: 2.
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT00751881. IPD Sharing: Not stated. Countries: 26. Publications: 6.
A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)
ClinicalTrials.gov study NCT03606460. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00835770. IPD Sharing: Not stated. Countries: 34. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.